We are live on
!
Find out more
KCM
Knoll Capital Management Portfolio holdings
AUM
$180M
1-Year Est. Return
66.11%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$153M
AUM Growth
+$6.81M
(+4.6%)
Cap. Flow
+$11.7M
Cap. Flow
% of AUM
7.6%
Top 10 Holdings %
Top 10 Hldgs %
82.43%
Holding
41
New
10
Increased
2
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLT
Applied Therapeutics
APLT
|
+$3.75M |
| 2 |
Elicio Therapeutics
ELTX
|
+$1.16M |
| 3 |
Booz Allen Hamilton
BAH
|
+$1.09M |
| 4 |
CVS Health
CVS
|
+$1.06M |
| 5 |
Arista Networks
ANET
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Anavex Life Sciences
AVXL
|
+$3.62M |
| 2 |
MTEM
Molecular Templates, Inc.
MTEM
|
+$1.07M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$52.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 79.18% |
| 2 | Materials | 5.78% |
| 3 | Financials | 2.61% |
| 4 | Technology | 2.11% |
| 5 | Communication Services | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MMX
26
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $606K | 0.39% |
115,000
| – | – |
|
|
SA
27
Seabridge Gold
SA
$3.35B
| $517K | 0.34% |
32,000
| – | – |
|
28
Franco-Nevada
FNV
$46B
| $470K | 0.31% |
3,750
| – | – |
|
29
OR Royalties Inc
OR
$6.2B
| $448K | 0.29% |
190,000
| – | – |
|
30
Agnico Eagle Mines
AEM
$90.5B
| $399K | 0.26% |
6,900
| – | – |
|
31
Equinox Gold
EQX
$13.5B
| $364K | 0.24% |
45,500
| – | – |
|
|
KL
32
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $363K | 0.24% |
10,750
| – | – |
|
33
Fortuna Silver Mines
FSM
$3.07B
| $283K | 0.18% |
43,700
| – | – |
|
|
MAG
34
DELISTED
MAG Silver
MAG
| $260K | 0.17% |
17,300
| – | – |
|
|
SILV
35
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $250K | 0.16% |
31,000
| – | – |
|
36
Pan American Silver
PAAS
$21.6B
| $246K | 0.16% |
8,200
| – | – |
|
|
SVM
37
Silvercorp Metals
SVM
$2.53B
| $179K | 0.12% |
36,500
| – | – |
|
|
38
Anavex Life Sciences
AVXL
$310M
| – | – |
-670,789
| Closed | -$3.62M |
|
|
MTEM
39
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
-7,594
| Closed | -$1.07M |
|
Similar funds
FBC
AIC
AG
PCA
HIC
FFA
V
RVM
Knoll Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Knoll Capital Management held 41 positions worth $153M, up 4.6% from $147M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Knoll Capital Management deployed $11.7M of net new capital in Q1 2021, opening 10 new positions and adding to 2 existing holdings. Its largest new stake was Elicio Therapeutics: 6,000 shares worth $1.08M.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 86% a quarter earlier, followed by Materials and Financials.
On the sell side, the largest reduction was Biohaven Pharmaceutical Holding Company Ltd., an estimated $52.6K trimmed.
- Knoll Capital Management's largest Q1 2021 buy was Elicio Therapeutics: 6,000 shares worth $1.08M.
- Knoll Capital Management added most to Applied Therapeutics in Q1 2021, an estimated $3.75M increase.
- Knoll Capital Management's biggest Q1 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $52.6K.
- Knoll Capital Management fully exited Anavex Life Sciences in Q1 2021, selling an estimated $3.62M.
- Knoll Capital Management's ten largest holdings make up 82% of its $153M portfolio in Q1 2021.
- Knoll Capital Management opened 10 new positions and closed 2 in Q1 2021.
- Knoll Capital Management's portfolio value rose 4.6% quarter-over-quarter to $153M.
Based on Knoll Capital Management's 13F filing for Q1 2021, filed 14 Jun 2021.